← Evidence map

ArticleCell death discovery2026

Inhibition of TGM2 enhances cisplatin sensitivity in MSH2-deficient bladder cancer.

Wenjie Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42209463